UB Paderborn / Katalog / Suche / in CDI

Influence of the Molecular Charge on the Biodistribution of Bombesin Analogues Labeled with the [99mTc(CO)3]-Core

Bioconjugate chemistry, 2008-12, Vol.19 (12), p.2409-2416

2008

Volltextzugriff (PDF)

Novel Glycated [99mTc(CO)3]-Labeled Bombesin Analogues for Improved Targeting of Gastrin-Releasing Peptide Receptor-Positive Tumors

Bioconjugate chemistry, 2008-12, Vol.19 (12), p.2432-2439

2008

Volltextzugriff (PDF)

The biodistribution of self-assembling protein nanoparticles shows they are promising vaccine platforms

Journal of nanobiotechnology, 2013-11, Vol.11 (1), p.36-36, Article 36

2013

Volltextzugriff (PDF)

Radiation dosimetry and biodistribution of 11C-ABP688 measured in healthy volunteers

European journal of nuclear medicine and molecular imaging, 2008-04, Vol.35 (4), p.766-770

2008

Volltextzugriff (PDF)

Preclinical evaluation of a new, stabilized neurotensin(8--13) pseudopeptide radiolabeled with (99m)tc

The Journal of nuclear medicine (1978), 2002-03, Vol.43 (3), p.374-383

2002

Volltextzugriff (PDF)

In vivo Evaluation of 177Lu- and 67/64Cu-Labeled Recombinant Fragments of Antibody chCE7 for Radioimmunotherapy and PET Imaging of L1-CAM-Positive Tumors

Clinical cancer research, 2005-07, Vol.11 (14), p.5112-5120

2005

Volltextzugriff (PDF)

Evaluation of a Novel Tc-99m Labelled Vitamin B12 Derivative for Targeting Escherichia coli and Staphylococcus aureus In Vitro and in an Experimental Foreign-Body Infection Model

Molecular imaging and biology, 2015-12, Vol.17 (6), p.829-837

2015

Volltextzugriff (PDF)

Glycation Methods for Bombesin Analogs Containing the (NαHis)Ac chelator for ⁹⁹mTc(CO)₃ Radiolabeling

Chemical biology & drug design, 2008-12, Vol.72 (6), p.496-506

2008

Volltextzugriff (PDF)

A stable neurotensin-based radiopharmaceutical for targeted imaging and therapy of neurotensin receptor-positive tumours

European journal of nuclear medicine and molecular imaging, 2009, Vol.36 (1), p.37-47

2009

Volltextzugriff (PDF)

Evaluation of a Novel Tc-99m Labelled Vitamin B^sub 12^ Derivative for Targeting Escherichia coli and Staphylococcus aureus In Vitro and in an Experimental Foreign-Body Infection Model

Molecular imaging and biology, 2015-12, Vol.17 (6), p.829

2015

Volltextzugriff (PDF)

Tumor imaging in patients with advanced tumors using a new (99m) Tc-radiolabeled vitamin B12 derivative

The Journal of nuclear medicine (1978), 2014-01, Vol.55 (1), p.43-49

2014

Volltextzugriff (PDF)

Chemical and biological characterization of new Re(CO)3 /[99m Tc](CO)3 bombesin analogues

Nuclear medicine and biology, 2007, Vol.34 (1), p.17-28

2007

Volltextzugriff (PDF)

Tumor Imaging in Patients with Advanced Tumors Using a New ^sup 99m^Tc-Radiolabeled Vitamin B12 Derivative

The Journal of nuclear medicine (1978), 2014-01, Vol.55 (1), p.43

2014

Volltextzugriff (PDF)

Tumor Imaging in Patients with Advanced Tumors Using a New 99m Tc-Radiolabeled Vitamin B12 Derivative

Journal of Nuclear Medicine, 2014-01, Vol.55 (1), p.43-49

2014

Volltextzugriff (PDF)

Double-stabilized neurotensin analogues as potential radiopharmaceuticals for NTR-positive tumors

Nuclear medicine and biology, 2006-05, Vol.33 (4), p.495-503

2006

Volltextzugriff (PDF)

Carbohydrated [99mTc(CO)3](NαHis)Ac-Bombesin(7–14) analogs

Advances in experimental medicine and biology, 2009, Vol.611, p.409-410

2009

Volltextzugriff (PDF)

Novel 99mTc-Labeled Neurotensin Analogues with Optimized Biodistribution Properties

Journal of medicinal chemistry, 2006-03, Vol.49 (5), p.1833-1836

2006

Volltextzugriff (PDF)

Novel 99m Tc-Labeled Neurotensin Analogues with Optimized Biodistribution Properties

Journal of medicinal chemistry, 2006-03, Vol.49 (5), p.1833-1836

2006

Volltextzugriff (PDF)

PEGylation, increasing specific activity and multiple dosing as strategies to improve the risk-benefit profile of targeted radionuclide therapy with 177Lu-DOTA-bombesin analogues

EJNMMI research, 2012-06, Vol.2 (1), p.24-24, Article 24

2012

Volltextzugriff (PDF)

In vitro and in vivo evaluation of new radiolabeled neurotensin(8–13) analogues with high affinity for NT1 receptors

Nuclear medicine and biology, 2001-01, Vol.28 (1), p.75-84

2001

Volltextzugriff (PDF)

Glycation Methods for Bombesin Analogs Containing the ( N α His)Ac chelator for 99m Tc(CO) 3 Radiolabeling

Chemical biology & drug design, 2008-12, Vol.72 (6), p.496-506

2008

Volltextzugriff (PDF)

Measurement of the Extracellular Space in Brain Tumors Using 76Br-Bromide and PET

The Journal of nuclear medicine (1978), 2003-08, Vol.44 (8), p.1210-1218

2003

Volltextzugriff (PDF)

Preclinical Evaluation of a New, Stabilized Neurotensin(8-13) Pseudopeptide Radiolabeled with 99mTc

The Journal of nuclear medicine (1978), 2002-03, Vol.43 (3), p.374-383

2002

Volltextzugriff (PDF)

Stabilization of neurotensin analogues: effect on peptide catabolism, biodistribution and tumor binding

Nuclear medicine and biology, 2002-04, Vol.29 (3), p.321-327

2002

Volltextzugriff (PDF)

Radiolabeled Neurotensin Analog, 99mTc-NT-XI, Evaluated in Ductal Pancreatic Adenocarcinoma Patients

The Journal of nuclear medicine (1978), 2003-10, Vol.44 (10), p.1649-1654

2003

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Influence of the Molecular Charge on the Biodistribution of Bombesin Analogues Labeled with the [99mTc(CO)3]-Core

Novel Glycated [99mTc(CO)3]-Labeled Bombesin Analogues for Improved Targeting of Gastrin-Releasing Peptide Receptor-Positive Tumors

The biodistribution of self-assembling protein nanoparticles shows they are promising vaccine platforms

Radiation dosimetry and biodistribution of 11C-ABP688 measured in healthy volunteers

Preclinical evaluation of a new, stabilized neurotensin(8--13) pseudopeptide radiolabeled with (99m)tc

In vivo Evaluation of 177Lu- and 67/64Cu-Labeled Recombinant Fragments of Antibody chCE7 for Radioimmunotherapy and PET Imaging of L1-CAM-Positive Tumors

Evaluation of a Novel Tc-99m Labelled Vitamin B12 Derivative for Targeting Escherichia coli and Staphylococcus aureus In Vitro and in an Experimental Foreign-Body Infection Model

Glycation Methods for Bombesin Analogs Containing the (NαHis)Ac chelator for ⁹⁹mTc(CO)₃ Radiolabeling

A stable neurotensin-based radiopharmaceutical for targeted imaging and therapy of neurotensin receptor-positive tumours

Evaluation of a Novel Tc-99m Labelled Vitamin B^sub 12^ Derivative for Targeting Escherichia coli and Staphylococcus aureus In Vitro and in an Experimental Foreign-Body Infection Model

Tumor imaging in patients with advanced tumors using a new (99m) Tc-radiolabeled vitamin B12 derivative

Chemical and biological characterization of new Re(CO)3 /[99m Tc](CO)3 bombesin analogues

Tumor Imaging in Patients with Advanced Tumors Using a New ^sup 99m^Tc-Radiolabeled Vitamin B12 Derivative

Tumor Imaging in Patients with Advanced Tumors Using a New 99m Tc-Radiolabeled Vitamin B12 Derivative

Double-stabilized neurotensin analogues as potential radiopharmaceuticals for NTR-positive tumors

Carbohydrated [99mTc(CO)3](NαHis)Ac-Bombesin(7–14) analogs

Novel 99mTc-Labeled Neurotensin Analogues with Optimized Biodistribution Properties

Novel 99m Tc-Labeled Neurotensin Analogues with Optimized Biodistribution Properties

PEGylation, increasing specific activity and multiple dosing as strategies to improve the risk-benefit profile of targeted radionuclide therapy with 177Lu-DOTA-bombesin analogues

In vitro and in vivo evaluation of new radiolabeled neurotensin(8–13) analogues with high affinity for NT1 receptors

Glycation Methods for Bombesin Analogs Containing the ( N α His)Ac chelator for 99m Tc(CO) 3 Radiolabeling

Measurement of the Extracellular Space in Brain Tumors Using 76Br-Bromide and PET

Preclinical Evaluation of a New, Stabilized Neurotensin(8-13) Pseudopeptide Radiolabeled with 99mTc

Stabilization of neurotensin analogues: effect on peptide catabolism, biodistribution and tumor binding

Radiolabeled Neurotensin Analog, 99mTc-NT-XI, Evaluated in Ductal Pancreatic Adenocarcinoma Patients

Suchergebnisse filtern